Sutro Biopharma Inc (STRO)
3.83
-0.11
(-2.79%)
USD |
NASDAQ |
May 03, 16:00
3.84
+0.01
(+0.26%)
After-Hours: 20:00
Sutro Biopharma Net Income (TTM): -106.79M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -106.79M |
| September 30, 2023 | -172.45M |
| June 30, 2023 | -142.66M |
| March 31, 2023 | -130.14M |
| December 31, 2022 | -119.20M |
| September 30, 2022 | -122.74M |
| June 30, 2022 | -134.15M |
| March 31, 2022 | -114.29M |
| December 31, 2021 | -105.54M |
| September 30, 2021 | -126.96M |
| June 30, 2021 | -78.92M |
| March 31, 2021 | -42.89M |
| Date | Value |
|---|---|
| December 31, 2020 | -32.13M |
| September 30, 2020 | 12.63M |
| June 30, 2020 | -17.42M |
| March 31, 2020 | -61.09M |
| December 31, 2019 | -55.74M |
| September 30, 2019 | -42.45M |
| June 30, 2019 | -39.77M |
| March 31, 2019 | -37.52M |
| December 31, 2018 | -35.32M |
| September 30, 2018 | -49.17M |
| June 30, 2018 | -40.35M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-172.45M
Minimum
Sep 2023
12.63M
Maximum
Sep 2020
-85.93M
Average
-105.54M
Median
Dec 2021
Net Income (TTM) Benchmarks
| AnaptysBio Inc | -163.62M |
| ABVC BioPharma Inc | -10.52M |
| Reviva Pharmaceuticals Holdings Inc | -39.26M |
| Flora Growth Corp | -57.30M |
| Journey Medical Corp | -3.853M |